first personalized nanomedicine symposium

1INIP CPNM – First Personalized Nanomedicine Symposium at FIU

First Personalized

Nanomedicine Symposium

Monday, February 18, 2013 MARC Pavilion, 7:30 a.m. – 6 p.m.

The Institute of NeuroImmune Pharmacology (INIP) & The Center for Personalized Nanomedicine (CPNM)

D e p a r t m e n t o f I m m u n o l o g yH e r b e r t W e r t h e i m C o l l e g e o f M e d i c i n e

F l o r i d a I n t e r n a t i o n a l U n i v e r s i t y

Need Photo of MARC Bldg.

MissionThe mission of INIP is to develop and sustain a program of translational research and training in drug use/abuse, tobacco use and HIV/AIDS. The Institute aims to promote interdisciplinary translational research focusing on the interactions of the human immune system, substance use/abuse, tobacco use, HIV infection, cancer and nanotechnology-based drug targeting.

CPNM is a research center at the Institute of NeuroImmune Pharmacology within the Department of Immunology at FIU’s Herbert Wertheim College of Medicine. The CPNM focuses on current applications of nanotechnology in personalized medicine. This includes reconstructive surgery, targeted therapy, the latest research on nanodevices, drug development and delivery, the use of microelectronics and high precision lithography for the production of nanocomposites for personalized medical use. The Center involves researchers at FIU and across the globe. The CPNM’s main partners include the University of California, Emory University, Miami Children’s Hospital, Cleveland Clinic, and Baptist Hospital. The Center’s research has been funded by the National Institutes of Health (NIH), the National Science Foundation (NSF), the Department of Defense (DoD) and other state, federal and private foundations.

4 INIP CPNM – First Personalized Nanomedicine Symposium at FIU

NIH Panel

Jag Khalsa, Ph.D.

Chief, Medical Consequences Branch, Division of Pharmacotherapies and Medical ConsequencesNational Institutes of Health

Jeymohan Joseph, Ph.D.

Chief, Neuropathogenesis and Treatment ProgramHIV Neuropathogenesis, Genetics, and Therapeutics BranchNational Institutes of Health

Christopher Weis, Ph.D. DABT

Toxicology Liaison / Senior Advisor, Office of the Director—National Institute of Environmental Health Sciences National Institutes of Health

Belinda Seto, Ph.D.

Deputy Director, National Institute of Biomedical Imaging and BioengineeringNational Institutes of Health

Kendall Bryant, Ph.D.

Director, Alcohol and AIDS ResearchNational Institute on Alcohol Abuse and AlcoholismNational Institutes of Health


Conference Agenda

Registration

7:30 a.m. - 8:00 a.m.

Welcome – Breakfast

8:00 a.m. - 8:30 a.m. Ileana Varela Associate Director of Marketing and PR

FIU Herbert Wertheim College of Medicine

8:30 a.m. - 8:40 a.m. Douglas Wartzok Ph.D. Provost & Executive Vice President FIU

8:40 a.m. - 8:50 a.m. John A. Rock, M.D., M.S.PH. Founding Dean, FIU Herbert Wertheim College of Medicine

Senior Vice President for Health Affairs FIU

Keynote Speaker

8:50 a.m. - 9:20 a.m. Molecular Medicine: Mechanism-Based Approaches

Belinda Seto, Ph.D. Deputy Director

National Institute of Biomedical Imaging and Bioengineering National Institutes of Health

Introduced by Madhavan Nair, Ph.D. Associate Dean, Biomedical Research Co-Director, Center for Personalized Nanomedicine FIU Herbert Wertheim College of Medicine

The Institute of NeuroImmune Pharmacology (INIP) & The Center for Personalized Nanomedicine (CPNM)

First Personalized Nanomedicine Symposium


Session 1

Nanomaterials and Nanodevices

Introduced by: Arvind Agarwal, Ph.D. Professor, Department of Mechanical and Materials Engineering,

FIU College of Engineering and Computing

Chair: Christopher Weis, Ph.D. DABT Toxicology Liaison, Senior Advisor, Office of the Director

National Institutes of Health

Co – Chair: Jeymohan Joseph, Ph.D.Chief, Neuropathogenesis and Treatment Program

National Institute of Mental Health, National Institutes of Health

9:20 a.m. – 9:40 a.m. Biomimetic Nanomedicine: Protocells and Virus-like Particles against Cancer and Infectious Disease

Eric Jakobsson, Ph.D. Professor, The School of Molecular and Cellular Biology University of Illinois at Urbana – Champaign

9:40 a.m. – 9:55 a.m. Applications of Carbon Nanotubes in Biology and Medicine

Robert Haddon, Ph.D. Distinguished Professor of Chemical and Environmental

Engineering, University of California, Riverside

9:55 a.m. – 10:15 a.m. Multifunctional Nanoparticles to Enable Personalized Nanomedicine

Sakhrat Khizroev, Ph.D. Professor and Vice Chair, Department of Immunology

Director, Center for Personalized Nanomedicine, FIU Herbert Wertheim College of Medicine

10:15 a.m. – 10:35 a.m. Nanoscale Regenerative Rare Earth Oxides for Nanomedicine

Sudipta Seal, Ph.D. Professor, Advanced Materials Processing and

Analysis Center (AMPAC), University of Central Florida

10:35 a.m. – 10:50 a.m. BREAK


Session 2

Nanoengineering and Single Molecule Imaging

Introduced by: Amir Mirmiran, Ph.D., P.E. Professor of Civil Engineering,

Dean, FIU College of Engineering and Computing

Chair: Belinda Seto, Ph.D. Deputy Director National Institute of Biomedical Imaging

and Bioengineering, National Institutes of Health

Co – Chair: Aftab Ahmed Ansari, Ph.D.Professor of Pathology, Emory University

10:50 a.m. – 11:10 a.m. Engineering Feedback System Control (FSC) Enabled Personalized Medicine

Chih-Ming Ho, Ph.D. Ben Rich-Lockheed Martin Chair Professor Henry Samueli School of Engineering and applied science Department of Mechanical & Aerospace Engineering Department of Bioengineering, UCLA

11:10 a.m. – 11:30 a.m. Nanobioelectronics for Theranostics

Chenzhong Li, Ph.D. Associate Professor

Department of Biomedical Engineering FIU

11:30 a.m. – 11:50 a.m. Enhanced Diagnostic Magnetic Resonance Imaging

Ping Liang, Ph.D. Associate Professor

Department of Electrical Engineering University of California, Riverside

11:50 a.m. – 12:10 p.m. Single-Molecule Enzymology with Nanometer-Scale Electronics

Gregory Weiss, Ph.D. Professor, Department of Chemistry

University of California, Irvine

12:10 p.m. – 1:15 p.m. LUNCH (FROST MUSEUM CAFE)


Session 3

Nanoengineering for Personalized Medicine

Introduced by: Carolyn Runowicz, M.D. Executive Associate Dean for Academic Affairs

Professor of Obstetrics and Gynecology FIU Herbert Wertheim College of Medicine

Chair: Jag Khalsa, Ph.D. Chief, Medical Consequences Branch, Division of Pharmacotherapies and Medical Consequences of Drug Abuse, National Institute on Drug Abuse,

National Institutes of Health

Co – Chair: Walter Royal, III, M.D.Director, The Maryland Center for Multiple Sclerosis Treatment and Research

University of Maryland

1:15 p.m. – 1:35 p.m. Anti-Angiogenic Nanotherapy for the Treatment of Inflammatory Arthritis

Christine Pham, M.D. Associate Professor, Division of Rheumatology Washington University School of Medicine

1:35 p.m. – 1:55 p.m. Nanomotor and RNA Nanotechnology for Personated Nanomedicine

Peixuan Guo, Ph.D. William Farish Endowed Chair in Nanobiotechnology

Director, Nanobiotechnology Center, University of Kentucky

1:55 p.m. – 2:15 p.m. A Nanotechnology Approach to Protect Human Neurons and Glia from Oxidative Stress

Anuja Ghorpade, Ph.D. Chair, Department of Cell Biology and Anatomy

University of North Texas Health Science Center

2:15 p.m. – 2:35 p.m. Epigenetic Modulation for Cancer Therapy

Vinod Labhasetwar, Ph.D. Professor, Department of Biomedical Engineering (ND20)

Cleveland Clinic Lerner Research Institute

2:35 p.m. – 2:50 p.m. BREAK


Session 4

New Engineering for Personalized Diagnostics/Treatments

Introduced by: Andrés G. Gil, Ph.D. Vice President for Research

Professor of Social Work FIU

Chair: Kendall Bryant, Ph.D. Director, Alcohol and AIDS Research, National Institute on Alcohol Abuse

and Alcoholism, National Institutes of Health

Co – Chair: Michal Toborek, MD, Ph.D.Professor and Vice-Chair, Research Department of Biochemistry and

Molecular Biology, University of Miami, Miller School of Medicine

2:50 p.m. – 3:10 p.m. Epitope Presentation Using Gold Nanoparticles for Immunoassay Development and In Vivo Studies

David Cliffel, Ph.D. Associate Professor, Department of Chemistry Vanderbilt University

3:10 p.m. – 3:30 p.m. Pre-Clinical Models of Personalized Medicine: Monitoring Therapy with Non-Invasive Imaging

Francois Villinger, D.V.M., Ph.D. Professor, Division of Pathology

Emory University School of Medicine

3:30 p.m. – 3:50 p.m. Targeting MicroRNAs to Ovarian Cancer

Sundaram Ramakrishnan, Ph.D. Professor, Department of Pharmacology

University of Minnesota

3:50 p.m. – 4:10 p.m. Immunomodulatory Nano-Scale Coatings for Islet Transplantation

Cherie Stabler, Ph.D. Associate Professor, Biomedical Engineering

Diabetes Research Institute, University of Miami

4:10 p.m. – 4:25 p.m. BREAK


4:25 p.m. – 5:25 p.m. PANEL DISCUSSION

Leaders: Robert Haddon, University of California, Riverside Jag Khalsa, NIH Christopher Weis, NIH/NIEHS Paul S. Weiss, University of California, Los Angeles

Discussants: Kendall Bryant, NIAAA/NIH Sulie Chang, Seton Hall University David Cliffel, Vanderbilt University Peixuan Guo, University of Kentucky Chih-Ming Ho, UCLA Eric Jakobsson, University of Illinois Jeymohan Joseph, NIMH/NIH Sakhrat Khizroev, FIU Mahendra Kumar, University of Miami Ping Liang, University of California, Riverside Anthony McGoron, FIU Sanjay B. Maggirwar, University of Rochester Medical Center Zubin Panthaki, University of Miami Christine Pham, Washington University Sabita Roy, University of Minnesota Francois Villinger, Emory University Gregory Weiss, University of California, Irvine

5:25 p.m. – 5:55 p.m. Summary - Panel Discussant Leaders

5:55 p.m. – 6:00 p.m. Thank You

Sakhrat Khizroev, Ph.D. Professor and Vice Chair, Department of Immunology Director, Center for Personalized Nanomedicine, FIU Herbert Wertheim College of Medicine

6:00 p.m. – 7:00 p.m. DINNER (FROST MUSEUM CAFE)

Panel Discussion


We would like to express our sincere appreciation to all attendees of today’s First Personalized Nanomedicine Symposium 2013. This event will open the doors to individualized treatment paradigms for the diagnosis and treatment of patients. Your participation has been invaluable to this event and will help it to become the premier vehicle for knowledge and innovation to professionals in this field. You are making a difference and we are honored to have you as our guests. Thank you for your support.

Madhavan Nair, Ph.D.Professor and Founding Chair, Department of ImmunologyDirector, Institute of Neuroimmune PharmacologyAssociate Dean, Biomedical ResearchFIU Herbert Wertheim College of Medicine

Sakhrat Khizroev, Ph.D.Professor and Vice Chair, Department of ImmunologyDirector, Center for Personalized NanomedicineFIU Herbert Wertheim College of Medicine

Thank You

Herbert Wertheim College of Medicine11200 SW 8th Street, AHC2

Miami, FL 33199305-348-0570 | medicine.fiu.edu

Florida International University Herbert Wertheim College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide

continuing medical education for physicians.

Florida International University Herbert Wertheim College of Medicine designates this live activity for a maximum of 6.5 AMA PRA Category 1 Credit(s)™. Physicians should claim

only the credit commensurate with the extent of their participation in the activity.

The FIU Herbert Wertheim College of Medicine is fully accredited by the Liaison Committee on Medical Education (LCME).

go.fiu.edu/nanomedicine

first personalized nanomedicine symposium

Documents

i n t e r n

t i o n

o r i d

e n t o f

e g e o f

e d i c i n ef

personalized medicine

personalized medical